Tamil Nadu to launch trial to study efficacy of BCG vaccine in the elderly
Published
The study will focus on the vaccine’s potential in reducing morbidity due to COVID-19, preventing hospitalisation, and reducing mortality
Full ArticlePublished
The study will focus on the vaccine’s potential in reducing morbidity due to COVID-19, preventing hospitalisation, and reducing mortality
Full ArticleThis study will be carried out in six states (sites) of the country--Tamil Nadu, Maharashtra, Gujarat, Madhya Pradesh, Rajasthan,..
As ordered by Chief Minister E Palaniswami, the BCG vaccine shall be administered on a trial basis, on adults aged 60-95, with the..